SCHEMBL5866970

SCHEMBL5866970

c1ccc2c(-c3nc4ccc(Cc5ccnnn5)cc4[nH]3)n[nH]c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 14/20 0.56
FLT1 P17948 10/20 0.56
ITK Q08881 2/20 0.56
CHEK1 O14757 4/20 0.53
PDPK1 O15530 3/20 0.53
ABL1 P00519 3/20 0.53
JAK2 O60674 3/20 0.53
FLT3 P36888 3/20 0.53
JAK3 P52333 3/20 0.53
CLK4 Q9HAZ1 3/20 0.53
KDR P35968 3/20 0.53
AURKA O14965 2/20 0.53
MAP4K4 O95819 2/20 0.53
PAK4 O96013 2/20 0.53
LCK P06239 2/20 0.53
RET P07949 2/20 0.53
PRKACA P17612 2/20 0.53
MAPK8 P45983 2/20 0.53
CSNK1A1 P48729 2/20 0.53
CLK2 P49760 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3533865 0.79 ITK (0.67) FGFR1FLT1ITKCHEK1PDPK1
SCHEMBL29714859 0.72 FGFR1 (1.00) FGFR1FLT1ITKCHEK1PDPK1
SCHEMBL311148 0.72 FGFR1 (1.00) FGFR1FLT1ITKCHEK1PDPK1
SCHEMBL5951325 0.72 ITK (0.71) FGFR1FLT1ITKCHEK1PDPK1
SCHEMBL4918041 0.72 PDPK1 (0.76) FGFR1FLT1ITKCHEK1PDPK1
SCHEMBL3541234 0.72 ITK (0.71) FGFR1FLT1ITKCHEK1PDPK1
SCHEMBL3533869 0.72 ITK (0.67) FGFR1FLT1ITKCHEK1PDPK1
SCHEMBL3535637 0.72 FGFR1 (1.00) FGFR1FLT1ITKCHEK1PDPK1
SCHEMBL5866975 0.71 ITK (0.56) FGFR1FLT1ITKCHEK1PDPK1
SCHEMBL13375206 0.70 ITK (0.67) FGFR1FLT1ITKCHEK1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7064215-B2 Indazole benzimidazole compounds CHIRON CORPORATION (US) 2006-06-20 US disclosed
US-20030207883-A1 Indazole benzimidazole compounds CHIRON CORPORATION 2003-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207883-A1 Indazole benzimidazole compounds SLCO1B3, SLCO1B1, SLCO4C1 FGFR1 2175/4885FLT1 3562/4885ITK 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.